BEIJING ENT (00392) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend

Bulletin Express03-12

Beijing Enterprises Holdings Limited (BEIJING ENT, stock code 00392) has scheduled a board meeting for 26 March 2026 at its Hong Kong headquarters on the 66th Floor of Central Plaza, 18 Harbour Road, Wanchai.

The board will review and approve the consolidated annual results for the financial year ended 31 December 2025 and deliberate on a potential final dividend recommendation.

As of the announcement date (12 March 2026), the board comprises: • Executive Directors: Chairman YANG Zhichang, Chief Executive Officer XIONG Bin, XU Tong, GENG Chao and TUNG Woon Cheung Eric. • Non-Executive Directors: YU Xijian and SU Junjie. • Independent Non-Executive Directors: WU Jiesi, LAM Hoi Ham, Dr. YU Sun Say and CHAN Man Ki Maggie.

The company will publish its FY 2025 results and any final dividend proposal following board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment